Vogcare GM2-0.2 Tablets – Glimepiride 2mg Metformin 500mg Voglibose 0.3mg Tablets Manufacturer, Supplier, Franchise In India

Vogcare GM2-0.2 Tablets are a triple-drug oral antidiabetic formulation designed for effective management of type 2 diabetes mellitus in adults. This combination is prescribed when blood glucose levels are not adequately controlled with diet, exercise, or dual-drug therapy alone. By targeting multiple pathways of glucose regulation, Vogcare GM2-0.2 helps achieve better and more consistent glycemic control. Glimepiride stimulates the pancreas to release insulin, helping lower elevated blood sugar levels. Metformin improves insulin sensitivity, reduces glucose production in the liver, and limits glucose absorption from the intestine. Voglibose slows down the digestion and absorption of carbohydrates, thereby controlling post-meal blood sugar spikes. Together, these three agents work synergistically to maintain balanced blood glucose levels throughout the day.

Key Benefits of Glimepiride 2mg Metformin 500mg Voglibose 0.3mg Tablets

Vogcare GM2-0.2 Tablets effectively control both fasting and post-prandial blood glucose levels, making them suitable for long-term diabetes management. The triple-action mechanism helps reduce insulin resistance, enhance insulin secretion, and prevent sudden rises in blood sugar after meals.